Overview
Miltenyi Biotec provides research- and clinical-grade products for sample preparation, cell separation, flow cytometry, and cell culture. Miltenyi Bioindustry, its CDMO division, offers services for developing and manufacturing cell and gene therapies, including lentiviral vectors, from preclinical to commercial scale. The company supports immunotherapy, regenerative medicine, and graft engineering with automated systems like CliniMACS Prodigy.
Frequently asked questions
- What CDMO capabilities does Miltenyi Biotec offer for cell and gene therapy?
- Miltenyi Bioindustry provides end-to-end CDMO services for cell-based therapies and lentiviral vectors, from preclinical development to commercial manufacturing, using automated systems like CliniMACS Prodigy with capacity for over 1000 batches per year at sites including San Jose.
- What products does Miltenyi Biotec provide for research and clinical applications?
- They offer research- and clinical-grade products for sample preparation, cell separation, flow cytometry, cell culture, antibodies for multiple applications, and spatial biology tools.
- What are Miltenyi Biotec's global manufacturing sites and regulatory compliance?
- Miltenyi operates five global Bioindustry sites, including a Cell Therapy Center of Excellence in San Jose, California, with GMP-compliant facilities supporting automated cell processing for clinical and commercial therapies.